HC Wainwright & Co. Initiates Coverage On Anebulo Pharmaceuticals With Buy Rating, Announces Price Target of $6
HC Wainwright & Co. Initiates Coverage On Anebulo Pharmaceuticals With Buy Rating, Announces Price Target of $6
HC Wainwright & Co.以买入评级开始对Anebulo Pharmicals进行报道，宣布目标股价为6美元
HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Anebulo Pharmaceuticals (NASDAQ:ANEB) with a Buy rating and announces Price Target of $6.
HC Wainwright&Co.分析师Raghuram Selvaraju以买入评级启动对AneBulo制药(纳斯达克：ANEB)的报道，并宣布目标价为6美元。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
资讯热榜
更新时间